English | 繁體

Search in the results

UM

Browse/Search Results:  1-10 of 87 Help

Selected(0)Clear Items/Page:    Sort:
A Robust ROS Generation and Ferroptotic Lipid Modulation Nanosystem for Mutual Reinforcement of Ferroptosis and Cancer Immunotherapy Journal article
Jiang, Chao, Li, Wenxi, Yan, Jie, Yu, Xinying, Feng, Yuzhao, Li, Bei, Liu, Yuan, Dai, Yunlu. A Robust ROS Generation and Ferroptotic Lipid Modulation Nanosystem for Mutual Reinforcement of Ferroptosis and Cancer Immunotherapy[J]. Advanced Healthcare Materials, 2024, 2401502.
Authors:  Jiang, Chao;  Li, Wenxi;  Yan, Jie;  Yu, Xinying;  Feng, Yuzhao; et al.
Favorite | TC[WOS]:0 TC[Scopus]:0  IF:10.0/11.3 | Submit date：2024/10/10
Cancer Immunotherapy  Ferroptosis  Ferroptotic Lipids  Immunogenic Cell Death  Reactive Oxygen Species  
Dexamethasone-loaded ROS stimuli-responsive nanogels for topical ocular therapy of corneal neovascularization Journal article
Xiang, Yongguo, Qiu, Zhu, Ding, Yuanfu, Du, Miaomiao, Gao, Ning, Cao, Huijie, Zuo, Hangjia, Cheng, Hong, Gao, Xiang, Zheng, Shijie, Wan, Wenjuan, Huang, Xiaobei, Hu, Ke. Dexamethasone-loaded ROS stimuli-responsive nanogels for topical ocular therapy of corneal neovascularization[J]. Journal of Controlled Release, 2024, 372, 874-884.
Authors:  Xiang, Yongguo;  Qiu, Zhu;  Ding, Yuanfu;  Du, Miaomiao;  Gao, Ning; et al.
Favorite | TC[WOS]:1 TC[Scopus]:2  IF:10.5/10.6 | Submit date：2024/08/05
Nanogel  Host-guest Interaction  Corneal Neovascularization  Dexamethasone  Reactive Oxygen Species  Stimuli-responsive  
A scaffold vaccine to promote tumor antigen cross-presentation via sustained toll-like receptor-2 (TLR2) activation Journal article
Xie, Daping, Han, Congwei, Chen, Chonghao, Liao, Zhencheng, Campos de Souza, Senio, Niu, Yiming, Mano, João F., Dong, Lei, Wang, Chunming. A scaffold vaccine to promote tumor antigen cross-presentation via sustained toll-like receptor-2 (TLR2) activation[J]. Bioactive Materials, 2024, 37, 315-330.
Authors:  Xie, Daping;  Han, Congwei;  Chen, Chonghao;  Liao, Zhencheng;  Campos de Souza, Senio; et al.
Favorite | TC[WOS]:0 TC[Scopus]:0  IF:18.0/18.2 | Submit date：2024/05/16
Scaffold Vaccine  Tlr2 Agonist  Polysaccharide  Reactive Oxygen Species  Cross-presentation  
Nanoenabled intracellular zinc bursting for efficacious reversal of gefitinib resistance in lung cancer Journal article
Li, Junnan, Assaraf, Yehuda G., Zuo, Weimin, Lin, Ziqi, Leong, Ka Weng, Zhao, Qi, Zhu, Lipeng, Kwok, Hang Fai. Nanoenabled intracellular zinc bursting for efficacious reversal of gefitinib resistance in lung cancer[J]. International Journal of Biological Sciences, 2024, 20(8), 3028-3045.
Authors:  Li, Junnan;  Assaraf, Yehuda G.;  Zuo, Weimin;  Lin, Ziqi;  Leong, Ka Weng; et al.
Favorite | TC[WOS]:2 TC[Scopus]:3  IF:8.2/8.3 | Submit date：2024/07/04
Cancer Therapy  Drug Resistance  Lung Cancer  Reactive Oxygen Species (Ros)  Zeolitic Imidazolate Framework-8 (Zif-8)  Zn2++++  
Cold Atmospheric Plasma: An Emerging Immunomodulatory Therapy Journal article
Liu, Hui, Liang, Xiaoliu, Teng, Minglei, Li, Zhenjie, Peng, Yisheng, Wang, Peiyu, Chen, Hu, Cheng, Hongwei, Liu, Gang. Cold Atmospheric Plasma: An Emerging Immunomodulatory Therapy[J]. Advanced Therapeutics, 2024, 7(5).
Authors:  Liu, Hui;  Liang, Xiaoliu;  Teng, Minglei;  Li, Zhenjie;  Peng, Yisheng; et al.
Favorite | TC[WOS]:2 TC[Scopus]:2  IF:3.7/4.7 | Submit date：2024/12/26
cold atmospheric plasma  combined therapy  immunomodulation  reactive oxygen species  tumor treatment  
Cold Atmospheric Plasma: An Emerging Immunomodulatory Therapy Review article
2024
Authors:  Liu, Hui;  Liang, Xiaoliu;  Teng, Minglei;  Li, Zhenjie;  Peng, Yisheng; et al.
Favorite | TC[WOS]:2 TC[Scopus]:2  IF:3.7/4.7 | Submit date：2024/05/16
Cold Atmospheric Plasma  Combined Therapy  Immunomodulation  Reactive Oxygen Species  Tumor Treatment  
Cancer Nanobombs Delivering Artoxplatin with a Polyigniter Bearing Hydrophobic Ferrocene Units Upregulate PD-L1 Expression and Stimulate Stronger Anticancer Immunity Journal article
Gao,Yongchao, Zhang,Hanchen, Tang,Lin, Li,Feifei, Yang,Li, Xiao,Haihua, Karges,Johannes, Huang,Weihua, Zhang,Wei, Liu,Chaoyong. Cancer Nanobombs Delivering Artoxplatin with a Polyigniter Bearing Hydrophobic Ferrocene Units Upregulate PD-L1 Expression and Stimulate Stronger Anticancer Immunity[J]. Advanced Science, 2024, 11(4), 2300806.
Authors:  Gao,Yongchao;  Zhang,Hanchen;  Tang,Lin;  Li,Feifei;  Yang,Li; et al.
Favorite | TC[WOS]:13 TC[Scopus]:15  IF:14.3/16.3 | Submit date：2023/08/03
Artoxplatin  Chemo-immunotherapy  Immunogenic Cell Death  Oxaliplatin  Reactive Oxygen Species  
GSH/pH Dual Activatable Cross-linked and Fluorinated PEI for Cancer Gene Therapy Through Endogenous Iron De-Hijacking and in Situ ROS Amplification Journal article
Yang, Suleixin, Wu, Yi, Zhong, Wenzhao, Chen, Ruie, Wang, Meilin, Chen, Meiwan. GSH/pH Dual Activatable Cross-linked and Fluorinated PEI for Cancer Gene Therapy Through Endogenous Iron De-Hijacking and in Situ ROS Amplification[J]. Advanced Materials, 2024, 36(2).
Authors:  Yang, Suleixin;  Wu, Yi;  Zhong, Wenzhao;  Chen, Ruie;  Wang, Meilin; et al.
Favorite | TC[WOS]:36 TC[Scopus]:32  IF:27.4/30.2 | Submit date：2024/02/22
Cancer Gene Therapy  Endogenous Iron De-hijacking  Ferroptosis  Lipid Peroxide  Mitochondria Damage  Reactive Oxygen Species  
Dynamic immuno-nanomedicines in oncology Review article
2024
Authors:  Ling, Hao;  Zhang, Qinyi;  Luo, Qiuhua;  Ouyang, Defang;  He, Zhonggui; et al.
Favorite | TC[WOS]:0 TC[Scopus]:0  IF:10.5/10.6 | Submit date：2024/05/16
Cancer Immunotherapy  Dinms-mediated Immune Responses  Dynamic Immuno-nanomedicines (Dinms)  Immunologic Agents  Reactive Oxygen Species-based Dynamic Therapies  
Exploration and validation of a novel reactive oxygen species–related signature for predicting the prognosis and chemotherapy response of patients with bladder cancer Journal article
Li, Yulei, Zhang, Lulu, Xu, Gang, Chen, Jiajun, Zhao, Keyuan, Li, Mengyao, Jin, Jing, Peng, Chao, Wang, Kaifang, Pan, Shouhua, Zhu, Ke. Exploration and validation of a novel reactive oxygen species–related signature for predicting the prognosis and chemotherapy response of patients with bladder cancer[J]. Frontiers in Immunology, 2024, 15, 1493528.
Authors:  Li, Yulei;  Zhang, Lulu;  Xu, Gang;  Chen, Jiajun;  Zhao, Keyuan; et al.
Favorite | TC[WOS]:0 TC[Scopus]:0  IF:5.7/6.8 | Submit date：2025/01/13
Akr1b1  Bladder Cancer  Chemotherapy Response  Overall Survival  Prognostic Signature  Reactive Oxygen Species